NervGen Pharma Corp (NGEN) — Financial Flexibility Index
NervGen Pharma Corp (NGEN) has a Financial Flexibility Index of -0.33x as of September 2025. Free cash flow of CA$-5.32 Million (operating CF CA$-5.32 Million minus capex CA$0.00) represents 0% of total liabilities (CA$16.02 Million). Check NGEN tangible net assets ratio to evaluate the tangible quality of the company's equity base.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
NervGen Pharma Corp Financial Flexibility Index (2017–2024)
Historical Financial Flexibility Index trend for NervGen Pharma Corp across 8 annual periods. For the full cash flow conversion analysis, see cash efficiency ratio of NervGen Pharma Corp.
Annual Financial Flexibility Index for NervGen Pharma Corp (2017–2024)
Year-by-year free cash flow to debt coverage for NervGen Pharma Corp. Explore debt repayment capacity of NervGen Pharma Corp to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (CAD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -1.00x | CA$-16.84 Million | CA$-16.84 Million | CA$16.91 Million | ▼ -36.1% |
| 2023 | -0.73x | CA$-11.15 Million | CA$-11.30 Million | CA$15.25 Million | ▲ +57.1% |
| 2022 | -1.71x | CA$-17.76 Million | CA$-17.78 Million | CA$10.41 Million | ▲ +77.6% |
| 2021 | -7.63x | CA$-8.22 Million | CA$-8.27 Million | CA$1.08 Million | ▲ +8.6% |
| 2020 | -8.35x | CA$-6.30 Million | CA$-6.31 Million | CA$755.07K | ▲ +4.7% |
| 2019 | -8.76x | CA$-8.09 Million | CA$-8.09 Million | CA$923.95K | ▼ -459.1% |
| 2018 | -1.57x | CA$-913.26K | CA$-1.04 Million | CA$583.11K | ▲ +85.6% |
| 2017 | -10.91x | CA$-1.04 Million | CA$-1.04 Million | CA$95.06K | — |